English  |  正體中文  |  简体中文  |  2823515  
???header.visitor??? :  30390300    ???header.onlineuser??? :  983
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"hou j"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 18  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2023 Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial Ren, Z.;Ducreux, M.;Abou-Alfa, G.K.;Merle, P.;Fang, W.;Edeline, J.;Li, Z.;Wu, L.;Assenat, E.;Hu, S.;Rimassa, L.;Zhang, T.;Blanc, J.-F.;Pan, H.;Ross, P.;Yen, C.-J.;Tran, A.;Shao, G.;Bouattour, M.;Chen, Y.;Meyer, T.;Hou, J.;Tougeron, D.;Bai, Y.;Hou, M.-M.;Meng, Z.;Wu, J.;Li, V.;Chica-Duque, S.;Cheng, A.-L.
國立成功大學 2023 Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B Lim, Y.-S.;Chan, H.L.Y.;Ahn, S.H.;Seto, W.K.;Ning, Q.;Agarwal, K.;Janssen, H.L.A.;Pan, C.Q.;Chuang, W.L.;Izumi, N.;Fung, S.;Shalimar;Brunetto, M.;Hui, A.J.;Chang, T.-T.;Lim, S.G.;Abramov, F.;Flaherty, J.F.;Wang, H.;Yee, L.J.;Kao, J.-H.;Gane, E.;Hou, J.;Buti, M.
臺大學術典藏 2022-09-09T04:21:25Z APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis You H.; Ma X.; Efe C.; Wang G.; Jeong S.-H.; Abe K.; Duan W.; Chen S.; Kong Y.; Zhang D.; Wei L.; Wang F.-S.; Lin H.-C.; Yang J.M.; Tanwandee T.; Gani R.A.; Payawal D.A.; Sharma B.C.; Hou J.; Yokosuka O.; Dokmeci A.K.; Crawford D.; JIA-HORNG KAO; Piratvisuth T.; Suh D.J.; Lesmana L.A.; Sollano J.; Lau G.; Sarin S.K.; Omata M.; Tanaka A.; Jia J.
臺大學術典藏 2022-09-09T04:21:22Z Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data Lim Y.-S.; Seto W.-K.; Kurosaki M.; Fung S.; JIA-HORNG KAO; Hou J.; Gordon S.C.; Flaherty J.F.; Yee L.J.; Zhao Y.; Agarwal K.; Lampertico P.
臺大學術典藏 2021-09-04T05:16:56Z Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: A systematic review and meta-analysis of individual participant data Pavlovic V.; Yang L.; Chan H.L.-Y.; Hou J.; Janssen H.L.; JIA-HORNG KAO; Lampertico P.; Peng C.-Y.; Piratvisuth T.; Thompson A.J.; Wedemeyer H.; Wei L.; Wat C.
臺大學術典藏 2021-08-05T02:38:32Z Synthesis of mesoporous TiO2-B nanobelts with highly crystalized walls toward efficient H2 evolution Li P;Cao Q;Zheng D;Alshehri A.A;Alghamidi Y.G;Alzahrani K.A;Kim M;Hou J;Lai L;Yamauchi Y;Ide Y;Bando Y;Kim J;Malgras V;Lin J.; Li P; KEVIN CHIA-WEN WU et al.
臺大學術典藏 2021-07-03T03:34:47Z Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions Ahn S.H.; Chan H.L.Y.; PEI-JER CHEN; Cheng J.; Goenka M.K.; Hou J.; Lim S.G.; Omata M.; Piratvisuth T.; Xie Q.; Yim H.J.; Yuen M.-F.
臺大學術典藏 2021-07-03T03:34:25Z Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis Jiang S.; Yang Z.; Li W.; Li X.; Wang Y.; Zhang J.; Xu C.; PEI-JER CHEN; Hou J.; McCrae M.A.; Chen X.; Zhuang H.; Lu F.
臺大學術典藏 2021-01-12T12:53:48Z Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop Tan D.; Lee J.H.; Chen W.; Shimizu K.; Hou J.; Suzuki K.; Nawarawong W.; SHANG-YI HUANG; Sang Chim C.; Kim K.; Kumar L.; Malhotra P.; Chng W.J.; Durie B.; for the Asian Myeloma Network
臺大學術典藏 2020-04-22T07:09:02Z Geometric and electronic structure of a C60 monolayer on Ag(100) Zhang, X.; He, W.; Zhao, A.; Li, H.; Chen, L.; Pai, W.W.; Hou, J.; Loy, M.M.T.; Yang, J.; Xiao, X.

Showing items 1-10 of 18  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page